by | Dec 18, 2024 | Kim, Taeho
— Published Date: 12/18/2024
Value Proposition: First clinical application of super resolution (SR) MRI reconstruction for 2D cine MRI in real-time radiotherapy.
Technology Description
Researchers at Washington University in St. Louis have developed a novel application for super-resolution (SR) c…
by | Dec 18, 2024 | Klechevsky, Eynav, Pathak, Amit, Sarker, Bapi
— Published Date: 12/19/2024
Value Proposition: New method for expanding T cells against individualized tumor-specific mutational antigens.
Technology Description
Researchers at Washington University in St. Louis have developed a device that enables high-throughput production of patient specific …
by | Dec 13, 2024 | Silva-Fisher, Jessica
— Value Proposition: Long non-coding RNA as biomarker and therapeutic target for treating diagnosed multiple myeloma patients.
Technology Description
Researchers at Washington University in St. Louis have developed a long non-coding RNA as a diagnostic marker and clinical target for multiple my…
by | Jul 18, 2024 | Kim, Brian
—
Value proposition: Novel approach to treat chronic itch through the intrathecal or intranasal delivery of JAK inhibitors.
Technology Description
Researchers at Washington University in St. Louis have developed a new method for treating chronic idiopathic pruritus (CIP) in both patients and m…
by | Jun 11, 2024 | Berezin, Mikhail, Birman, Vladimir, Fuentes, Isaac, Tang, Rui
— Value proposition: Fluorescent oxonol dyes that can be used to enhance bioimaging for the treatment of cancer.
Technology Description
Researchers at Washington University in St. Louis have developed a new class of fluorescent oxonol dyes that exhibit absorption and emission in the near infrared…